MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Digestive Diseases and Sciences

• Publication date

  2020-09-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-020-06579-7PMID 32914380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.

  2019cited by this paper
• Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway.

  2019cited by this paper
• HSPA 12 B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI 3 K / Akt / NF-κ B signaling pathway

  2018cited by this paper
• Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels

  2018cited by this paper
• HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-κB signaling pathway.

  2018cited by this paper
• MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma

  2018cited by this paper
• Doxorubicin Action on Mitochondria: Relevance to Osteosarcoma Therapy?

  2018cited by this paper
• Liposomal Permeabilization Assay to Study the Functional Interactions of the BCL-2 Family.

  2018cited by this paper
• RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

  2018cited by this paper
• MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1

  2018cited by this paper
• MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer

  2018cited by this paper
• N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2

  2017cited by this paper
• Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.

  2017cited by this paper
• miR-135a promotes gastric cancer progression and resistance to oxaliplatin

  2016cited by this paper
• The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

  2015cited by this paper
• HSPA12B: a novel facilitator of lung tumor growth

  2015cited by this paper
• RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway

  2015cited by this paper
• Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer.

  2015cited by this paper
• miR‐203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

  2014cited by this paper
• Heat shock protein 70 is involved in malignant behaviors and chemosensitivities to cisplatin in cervical squamous cell carcinoma cells

  2014cited by this paper
• Insights in microRNAs biology.

  2013cited by this paper
• EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Molecular genetics of colorectal cancer.

  2011cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Control of mitochondrial apoptosis by the Bcl-2 family

  2009cited by this paper
• Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines

  2009cited by this paper
• Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.

  2008cited by this paper
• The colorectal microRNAome.

  2006cited by this paper
• Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

  2006cited by this paper
• Systemic therapy for colorectal cancer.

  2005cited by this paper
• Bcl-2 Rescues Ceramide- and Etoposide-induced Mitochondrial Apoptosis through Blockage of Caspase-2 Activation*

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  2004cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper

• Medicarpin reduces cisplatin resistance and causes apoptosis by inhibiting the AKT/Bcl2 pathway in breast cancer

  2025cites this paper
• Targeting the miR-325-3p/GSTP1 axis overcomes paclitaxel resistance in triple-negative breast cancer by inducing ferroptosis

  2025cites this paper
• Dysregulated miRNAs Targeting Adiponectin Signaling in Colorectal Cancer

  2025cites this paper
• Inhibition of miR-325 inhibits KIF20B expression and the colorectal cancer cells’ invasion & proliferation

  2025cites this paper
• Reversing Sunitinib Resistance Facilitated by ITGA1 Through the PI3K/Akt/Bcl-2 Pathway Using Nano Co-Delivery System in Renal Cell Carcinoma

  2024cites this paper
• MicroRNA‑325: A comprehensive exploration of its multifaceted roles in cancer pathogenesis and therapeutic implications (Review)

  2024influential citation
• Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets

  2023cites this paper
• TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2

  2023cites this paper
• Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer

  2023cites this paper
• Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

  2022cites this paper
• Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway

  2022cites this paper
• miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X

  2022cites this paper
• Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway.

  2021cites this paper
• LncRNA MSC-AS1 Promotes Colorectal Cancer Progression by Regulating miR-325/TRIM14 Axis

  2021cites this paper
• LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5

  2021cites this paper
• Ailanthone decreases cell viability in tongue squamous cell carcinoma via PI3K/AKT pathway

  2021cites this paper
• MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer

  2021cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper